Venous Thromboembolism in Critically Ill Cirrhotic Patients: Practices of Prophylaxis and Incidence
Table 2
Practices of VTE prophylaxis in cirrhotics and noncirrhotic critically ill patients.
Cirrhotic patients
Noncirrhotic patients
value
Use of mechanical prophylaxis, (%)
43 (57.3)
366 (50.6)
0.27
Intermittent pneumatic compression
23 (30.6)
232 (32.1)
0.86
Graduated compression stockings
22 (29.3)
175 (24.2)
0.29
Mechanical prophylaxis only
31 (41.3)
56 (7.7)
<0.0001
Use of pharmacologic prophylaxis, (%)
24 (32.0)
615 (85.1)
<0.0001
Unfractionated heparin
22 (29.3)
479 (66.3)
<0.0001
Low-molecular-weight heparin
2 (2.7)
225 (31.1)
<0.0001
Pharmacologic prophylaxis only
12 (16.0)
305 (42.2)
<0.0001
No VTE prophylaxis, (%)
20 (26.7)
52 (7.2)
<0.0001
Use of both mechanical and pharmacologic prophylaxis simultaneously, (%)
12 (16.0)
310 (42.9)
<0.0001
Duration of pharmacologic prophylaxis (days), mean ± SD
<0.0001
Duration of mechanical prophylaxis (days), mean ± SD
Intermittent pneumatic compression
0.13
Graduated compression stockings
0.41
Stay in the ICU without pharmacologic prophylaxis (days), mean ± SD
<0.0001
ICU: intensive care unit; SD: standard deviation. For patients who received pharmacologic prophylaxis. Data on thromboprophylaxis were obtained for a maximum of 30 days of ICU stay.